Daniela A. Bota - Concepedia

Author

Daniela A. Bota

Also Known As

B. D. Fu, Cynthia Campen, D A Bota, D Bota, D. A. Bota, D. Bota, D.A. Bota, Daniela A Bota, Daniela A. Bota, Daniela A. Bota, MD, PhD

318

Publications

7.7K

Citations

H-Index

135

Concepts

All Affiliations

University of California, Irvine Neurological Surgery University of California, Irvine Medical Center Duke Medical Center Washington University in St. Louis

About

Daniela A. Bota is an author at University of California, Irvine specializing in medicine, glioma, and neuro-oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	31	3K
2	Health Sciences	6	6	225
3	Social Sciences	5	5	342
4	Natural Sciences	3	3	858
5	Public Health	2	2	30

Daniela A. Bota

Publications

6.1K

Citations

H-Index

Page 1

	Year	Citations
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial Michael Weller, Nicholas Butowski, David Tran, The Lancet Oncology Egfrviii-expressing GlioblastomaNeuro-oncologyAct IvGliomaInternational Phase 3	2017	1.1K
Lon protease preferentially degrades oxidized mitochondrial aconitase by an ATP-stimulated mechanism Daniela A. Bota, Kelvin J.A. Davies Nature Cell Biology Atp-stimulated MechanismOxidized Mitochondrial AconitaseCellular EnzymologyMitochondrial FunctionBiochemistry	2002	555
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma Linda M. Liau, Keyoumars Ashkan, David D. Tran, Journal of Translational Medicine	2018	528
Deep-Learning Convolutional Neural Networks Accurately Classify Genetic Mutations in Gliomas Peter Chang, Jack Grinband, Brent D. Weinberg, American Journal of Neuroradiology	2018	475
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma Linda M. Liau, Keyoumars Ashkan, Steven Brem, JAMA Oncology	2022	356
Non-viral precision T cell receptor replacement for personalized cell therapy Susan P. Foy, Kyle Jacoby, Daniela A. Bota, Nature	2022	252
Modulation of Lon protease activity and aconitase turnover during aging and oxidative stress Daniela A. Bota, Holly Van Remmen, Kelvin J.A. Davies FEBS Letters	2002	234
Downregulation of the human Lon protease impairs mitochondrial structure and function and causes cell death Daniela A. Bota, Jenny K. Ngo, Kelvin J.A. Davies Free Radical Biology and Medicine MitophagyMitochondrial FunctionBiochemistryHuman Lon ProteaseMedicine	2004	206
Cisplatin-induced mitochondrial dysfunction is associated with impaired cognitive function in rats Naomi Lomeli, Kaijun Di, J Czerniawski, Free Radical Biology and Medicine ChromatinNeuropsychologyMitochondrial FunctionMitochondrial DynamicMedicine	2016	160
Clinical Practice Experience With NovoTTF-100A™ System for Glioblastoma: The Patient Registry Dataset (PRiDe) Maciej M. Mrugała, Herbert H. Engelhard, David Tran, Seminars in Oncology Surgical OncologyCancer ManagementCancer RegistrationHigh-grade GliomasGlioma	2014	143

Page 1